Prophylactic Heparin May Not Prevent Placental Insufficiency

Unfractionated heparin offers no advantage to standard care for risk of placental insufficiency

MONDAY, June 27 (HealthDay News) -- Women at risk of placental insufficiency who are treated with unfractionated heparin (UFH) during pregnancy may not have significantly better outcomes than those undergoing standard care, according to a study published online June 20 in the Journal of Thrombosis and Haemostasis.

John C.P. Kingdom, M.D., of the University of Toronto, and colleagues investigated the efficacy of UFH treatment in 32 women at high-risk of placental insufficiency in the second trimester. Thrombophilia screen-negative women, with either false-positive first- or second-semester serum tests or other medical/obstetric risk factors, were randomly allocated to receive 7500 IU UFH twice daily until birth or 34 weeks' gestation (16 women) or standard care. Sonography of the placenta and uterine artery Doppler were performed between 18 and 22 weeks. Maternal-infant outcomes, including maternal anxiety, were evaluated.

The investigators found no statistically major difference between the standard care group and the UFH group in the mean anxiety score, birth weight, perinatal death, severe preeclampsia, placental weight below the 10th percentile, or placental infarction.

"Our study design and findings, including placental pathology data, challenge the widely prevailing view that pregnant women should receive prophylactic heparin to improve perinatal outcomes based solely on clinical risk factors for placental insufficiency," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events